FDA MedWatch Safety Alerts http://www.fda.gov/medwatch en-us Fri, 09 May 2008 09:50:00 EDT jay.wattenberg@fda.hhs.gov Surgeons, dialysis center staff, hospital risk managers, other healthcare professionals FDA requests that health professionals and facilities review and examine all drug/device storage areas to ensure that all recalled heparin products have been removed and are no longer available for patient use. Fri, 09 May 2008 09:50:00 EDT http://www.fda.gov/medwatch/safety/2008/safety08.htm#HeparinInj2 http://www.fda.gov/medwatch/safety/2008/safety08.htm#HeparinInj2 Consumers, hospital and nursing home risk managers, healthcare professionals Product recalled because of the presence of Burkholderia cepacia. Tue, 06 May 2008 12:00:00 EDT http://www.fda.gov/medwatch/safety/2008/safety08.htm#Cardinal http://www.fda.gov/medwatch/safety/2008/safety08.htm#Cardinal Healthcare professionals Video news show for healthcare professionals, covering safety alerts, recalls, product approvals, and important tips on protecting patients. Tue, 06 May 2008 08:45:00 EDT http://www.fda.gov/psn http://www.fda.gov/psn Rheumatologists, dermatologists, other healthcare professionals, patients Prescribing information revised to include a BOXED WARNING regarding the risk of infection including tuberculosis. Thu, 01 May 2008 14:00:00 EDT http://www.fda.gov/medwatch/safety/2008/safety08.htm#Enbrel http://www.fda.gov/medwatch/safety/2008/safety08.htm#Enbrel Rheumatologists, dermatologists, other healthcare professionals, patients FDA analysis reveals high chromium levels in addition to selenium. Thu, 01 May 2008 14:00:00 EDT http://www.fda.gov/medwatch/safety/2008/safety08.htm#TotalBody http://www.fda.gov/medwatch/safety/2008/safety08.htm#TotalBody Surgeons, dialysis center staff, hospital risk managers, other healthcare professionals Update to healthcare facilities and healthcare professionals about Heparin and Heparin-containing medical products. Tue, 29 Apr 2008 08:55:00 EDT http://www.fda.gov/medwatch/safety/2008/safety08.htm#HeparinInj2 http://www.fda.gov/medwatch/safety/2008/safety08.htm#HeparinInj2 Cardiologists, family physicians, pharmacists, other healthcare professionals, patients Class I recall because tablets may contain twice the approved level of active ingredient. Mon, 28 Apr 2008 15:25:00 EDT http://www.fda.gov/medwatch/safety/2008/safety08.htm#Digitek http://www.fda.gov/medwatch/safety/2008/safety08.htm#Digitek Healthcare professionals Changes to the BOXED WARNING, WARNINGS, CONTRAINDICATIONS, PRECAUTIONS, and ADVERSE REACTIONS sections of the labels, plus Medication Guides and Patient Package Inserts. Thu, 24 Apr 2008 16:15:00 EDT http://www.fda.gov/medwatch/SAFETY/2008/jan08_quickview.htm http://www.fda.gov/medwatch/SAFETY/2008/jan08_quickview.htm Endocrinologists, clinical laboratory managers, risk managers, patients UPDATE -- Fatal Iatrogenic Hypoglycemia -- Life threatening falsely elevated blood glucose readings with a point-of-care meter due to a maltose-containing intravenous immune globulin product. Final report of an investigation issued. Tue, 22 Apr 2008 15:50:00 EDT http://www.fda.gov/medwatch/safety/2005/safety05.htm#maltose http://www.fda.gov/medwatch/safety/2005/safety05.htm#maltose Consumers, healthcare professionals Twelve dietary herbal supplements recalled because they contain ephedra, aristolochic acid or human placenta and may present a serious health hazard to consumers. Mon, 14 Apr 2008 13:50:00 EDT http://www.fda.gov/medwatch/safety/2008/safety08.htm#Herbal http://www.fda.gov/medwatch/safety/2008/safety08.htm#Herbal Transplantation specialists, infectious disease specialists Possible association between the use of these products and the development of progressive multifocal leukoencephalopathy. Thu, 10 Apr 2008 14:18:00 EDT http://www.fda.gov/medwatch/safety/2008/safety08.htm#mycophenolate http://www.fda.gov/medwatch/safety/2008/safety08.htm#mycophenolate Consumers UPDATE: Products found to contain hazardous levels of selenium. Thu, 10 Apr 2008 11:00:00 EDT http://www.fda.gov/medwatch/safety/2008/safety08.htm#TotalBody http://www.fda.gov/medwatch/safety/2008/safety08.htm#TotalBody Neurologists, other healthcare professionals, patients Product recalled due to formation of rotigotine crystals in the patches which may affect the efficacy of the product. Wed, 09 Apr 2008 16:45:00 EDT http://www.fda.gov/medwatch/safety/2008/safety08.htm#neupro http://www.fda.gov/medwatch/safety/2008/safety08.htm#neupro